Table 2.
Information of subjects (years of collection, age and sex) and serologic results (ELISA, IFA, MN and PRN titer) of the samples showing WNV neutralizing antibodies by MN/PRN assays.
| Years | Subject | Age Group | Age (Years) | Sex | ELISA IgG | IFA IgG | MN Titer | PRN Titer |
|---|---|---|---|---|---|---|---|---|
| 2016–2017 | 1 | >60 | 61 | F | Positive | 1/100 | 20 | 10 |
| 2 | >60 | 64 | M | Positive | 1/6400 | 20 | 40 | |
| 3 | 20–60 | 57 | F | Borderline | 1/50 | 20 | 10 | |
| 4 | >60 | 91 | F | Borderline | 1/50 | 20 | 20 | |
| 5 | 20–60 | 42 | F | Positive | 1/50 | 10 | 10 | |
| 6 | 20–60 | 33 | F | Positive | 1/800 | 10 | 40 | |
| 2018–2019 | 7 | 20–60 | 52 | M | Positive | 1/400 | 10 | 40 |
| 8 | >60 | 75 | M | Positive | 1/50 | 10 | 20 | |
| 9 | 20–60 | 30 | M | Positive | 1/3200 | 20 | 10 | |
| 10 | 20–60 | 32 | M | Positive | 1/6400 | 40 | 40 | |
| 11 | >60 | 85 | F | Positive | 1/100 | 20 | 20 |
IFA, immunofluorescence assay; MN, micro neutralization; PRN, plaque reduction neutralization.